Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

TSE:IN

Inmed Pharmaceuticals (IN.TO)

4.19
-0.07 (1.64%)
as of May 7, 2021, 8:00:00 pm Market Open.
2 watching
0
RISKY

This is another company in the cannabis space. This is not a cannabis producer, it is a company that adds value in that space. They are mapping cannabinoids, looking for different formulations to treat different diseases.It is highly speculative, but he thinks there is opportunity for this type of company. He likes the management. In a growth market, as the US opens up, this could do very well. He owns stocks like this in a basket. He is not betting on any one of them; instead he is expecting the overall basket to do well.

Showing 1 to 1 of 1 entries
  • «
  • 1
  • »

Inmed Pharmaceuticals (IN.TO) Frequently Asked Questions

What is Inmed Pharmaceuticals stock symbol?

Inmed Pharmaceuticals is a Canadian stock, trading under the symbol IN.TO (previously IN-T on Stockchase) on the Toronto Stock Exchange (IN-CT). It is usually referred to as TSX:IN or IN.TO

Is Inmed Pharmaceuticals a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on IN.TO (previously IN-T on Stockchase) on Stockchase. Read the latest expert commentary for Inmed Pharmaceuticals.

Is Inmed Pharmaceuticals a good investment or a top pick?

Inmed Pharmaceuticals was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Inmed Pharmaceuticals.

Why is Inmed Pharmaceuticals stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Inmed Pharmaceuticals.

Is Inmed Pharmaceuticals worth watching?

Inmed Pharmaceuticals is covered by Stockchase experts and is worth watching.

What is Inmed Pharmaceuticals stock price?

On 2021-05-07, Inmed Pharmaceuticals (IN.TO) stock closed at a price of $4.19.